Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in Egypt

Nov 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Cough remedies benefit from COVID-19

Cold, cough and allergy (hay fever) remedies are expected to register double-digit value growth in 2020, though not as high as value growth over the review period. However, a lot of value growth over the review period has been driven by inflationary pressure and the product area is expected to register an increase in volume sales, as result of the COVID-19 in 2020.

GSK inherits strong brands to become leading player

GSK Consumer Healthcare maintained its leadership position in 2020 in cough, cold and allergy (hay fever) remedies as it inherited leading brands such as Zyrtec, Otrivin and Comtrex through its acquisition of Novartis. All of these brands have been present on retail shelves in Egypt for many years and they all benefit from high levels of consumer recognition.

Demand remains highly seasonal in all product areas

COVID-19 temporarily changed consumer behaviour in terms of cough, cold and allergy (hay fever) remedies, as consumers in particular bought cough remedies in the spring in preparation of potentially being diagnosed with COVID-19. However, usually value sales are highly seasonal.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Egypt with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Egypt, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Egypt market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Egypt?
What are the major brands in Egypt?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in Egypt - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Cough remedies benefit from COVID-19

GSK inherits strong brands to become leading player

Demand remains highly seasonal in all product areas

RECOVERY AND OPPORTUNITIES

Growth in value sales decline in 2021 due to stockpiling

Value sales continue to be supported by strong preference for self-medication

Rigid price controls stymies growth during the forecast period

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

Consumer Health in Egypt - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Egypt

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Cough remedies benefit from COVID-19

GSK inherits strong brands to become leading player

Demand remains highly seasonal in all product areas

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Egypt - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Cough remedies benefit from COVID-19

GSK inherits strong brands to become leading player

Demand remains highly seasonal in all product areas

RECOVERY AND OPPORTUNITIES

Growth in value sales decline in 2021 due to stockpiling

Value sales continue to be supported by strong preference for self-medication

Rigid price controls stymies growth during the forecast period

CATEGORY DATA

Consumer Health in Egypt - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports